BioCentury
ARTICLE | Company News

NewGen, Kanion deal

January 2, 2012 8:00 AM UTC

NewGen acquired exclusive, ex-Chinese rights from Kanion's Kanion USA Inc. U.S. subsidiary to develop and commercialize three preclinical cancer programs. In exchange, Kanion received an undisclosed m...